Opus Genetics, Inc. (IRD)
2.36
+0.10
(+4.42%)
USD |
NASDAQ |
Jan 21, 16:00
2.355
0.00 (0.00%)
After-Hours: 20:00
Opus Genetics Market Cap: 162.76M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 185.02B |
| Zymeworks, Inc. | 1.806B |
| NovaBay Pharmaceuticals, Inc. | 740.64M |
| Palatin Technologies, Inc. | 15.16M |
| Theriva Biologics, Inc. | 6.475M |
Market Cap Related Metrics
| PS Ratio | 8.043 |
| PEG Ratio | -0.0236 |
| Price to Book Value | 27.28 |
| Price | 2.36 |
| Earnings Yield | -72.83% |
| PEGY Ratio | -0.0236 |